XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock and Other Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of unrecognized compensation cost, nonvested awards The following table represents expected amortization of the Company's non-vested shares issued as of December 31, 2023:
Dollars in millionsFUTURE AMORTIZATION
of non-vested shares
2024$12.2 
20259.7 
20266.9 
20272.1 
2028 and thereafter0.5 
Total$31.4 
Schedule of other than stock options, valuation assumptions a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions:
Volatility34.0 %
Dividend AssumptionAccrued
Expected term in years3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumption:
Volatility34.0 %
Dividend assumptionAccrued
Expected term 3 years
Risk-free rate4.42 %
Stock price (per share)$20.21
Schedule of the activity under the incentive plans the previous directors' plan
The following table represents the summary of non-vested share-based awards (including restricted stock, RSUs, LTIP-C units and LTIP-D units) under the Incentive Plans and related information for the three years ended December 31, 2023: 
YEAR ENDED DECEMBER 31,
Dollars in thousands, except per share data202320222021
Share-based awards, beginning of year2,090,060 1,562,028 1,766,061 
Granted 1
1,164,359 952,407 203,701 
Vested(403,266)(418,949)(404,777)
Change in awards based on performance assessment 2
(205,668)— — 
Forfeited(29,923)(5,426)(2,957)
Share-based awards, end of year2,615,562 2,090,060 1,562,028 
Weighted-average grant date fair value of
Share-based awards, beginning of year$30.35 $31.10 $30.51 
Share-based awards granted during the year$18.70 $29.64 $30.86 
Share-based awards vested during the year$28.38 $31.52 $28.38 
Share-based awards change in performance assessment during the year$29.05 $— $— 
Stock-based awards forfeited during the year$31.16 $31.48 $33.04 
Share-based awards, end of year$25.56 $30.35 $31.10 
Grant date fair value of shares granted during the year$22,171 $28,225 $6,286 
1LTIP-C units are issued at the maximum possible value of the award and are reflected as such in this table until the performance period has been satisfied and the exact number of awards are determinable.
2The Company's RSUs that are based on operating performance metrics are evaluated on the probability of those performance metrics being achieved. During 2023, the Company determined that the operating performance goals related to the RSUs issued in 2022 are not probable of being achieved and reversed all of the outstanding amortization expense for that grant. In addition, the Company lowered the probability of achieving the operating performance goals related to the RSUs issued in 2023.
Schedule of the employee stock purchase plan activity
A summary of the Legacy HR Employee Stock Purchase Plan activity and related information for the three years ended December 31, 2023 is as follows:
YEAR ENDED DECEMBER 31,
Dollars in thousands, except per share data202320222021
Options outstanding, beginning of year340,976 348,514 341,647 
Granted— 255,960 253,200 
Exercised(8,627)(20,246)(30,281)
Forfeited(43,737)(102,619)(71,630)
Expired(132,999)(140,633)(144,422)
Options outstanding and exercisable, end of year155,613 340,976 348,514 
Weighted-average exercise price of
Options outstanding, beginning of year$16.38 $25.38 $24.70 
Options granted during the year$— $26.89 $25.16 
Options exercised during the year$15.07 $20.97 $25.03 
Options forfeited during the year$15.50 $21.88 $25.45 
Options expired during the year$16.43 $23.36 $24.17 
Options outstanding, end of year$12.98 $16.38 $25.38 
Weighted-average fair value of options granted during the year (calculated as of the grant date)$— $9.91 $9.05 
Intrinsic value of options exercised during the year$23 $75 $165 
Intrinsic value of options outstanding and exercisable
(calculated as of December 31)
$401 $985 $1,997 
Exercise prices of options outstanding
(calculated as of December 31)
$14.65 $16.38 $25.91 
Weighted-average contractual life of outstanding options (calculated as of December 31, in years)0.30.80.8
Schedule of stock options, valuation assumptions
202320222021
Risk-free interest rates— %0.73 %0.13 %
Expected dividend yields— %3.97 %4.11 %
Expected life (in years)01.441.43
Expected volatility— %49.0 %48.2 %
Expected forfeiture rates— %85 %85 %